Journal of Guangxi Normal University(Natural Science Edition) ›› 2020, Vol. 38 ›› Issue (1): 93-101.doi: 10.16088/j.issn.1001-6600.2020.01.012
Previous Articles Next Articles
LONG Jingxian1, PAN Yumin2, PAN Guolü2, HUANG Rongcheng2, PENG Yan2*
CLC Number:
[1] OLAMIDE H M, RAQUEL D, THERESE D P, et al. Transforming growth factor-β protects against inflammation-related atherosclerosis in South African CKD patients[J]. International Journal of Nephrology, 2018, 2018: 1-11. [2] YAMAGUCHI J, TANAKA T, NANGAKU M. Recent advances in understanding of chronic kidney disease[J]. F1000 Research, 2015, 4: 1-9. [3] NAKAGAWA N, DUFFIELD J S. Myofibroblasts in fibrotic kidneys[J]. Current Pathobiology Reports, 2013, 1 (3): 189-198. [4] 宗妍. 益气活血降浊方对肾间质纤维化TGF-β1/Smads/BMP-7信号转导通路影响的实验研究[D]. 北京:北京中医药大学, 2011. [5] ZHANG Y, WANG S, LIU S, et al. Role of Smad signaling in kidney disease[J]. International Urology and Nephrology, 2015, 47 (12): 1965-1975. [6] HUI Y L. Diverse Roles of TGF-β/Smads in renal fibrosis and inflammation[J]. International Journal of Biological Sciences, 2011, 7 (7):1056-1067. [7] WANG K F, LIU H Y, WANG B, et al. Effects of intrathecal injection of methylprednisolone sodium succinate in acute spinal cord injury rabbits[J]. Chinese Journal of Surgery, 2013, 51 (5): 426. [8] YAO Q M, LI PP, LIANG S M, et al. Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression[J]. International Journal of Clinical and Experimental Pathology, 2015, 8 (7): 7921-7928. [9] PORCARO F, PAGLIETTI M G, DIAMANTI A, et al. Anaphylactic shock with methylprednisolone sodium succinate in a child with short bowel syndrome and cow’s milk allergy[J]. Italian Journal of Pediatrics, 2017, 43(1):104. [10]CHENG S, GAO W, XU X, et al. Methylprednisolone sodium succinate reduces BBB disruption and inflammation in a model mouse of intracranial haemorrhage[J]. Brain Research Bulletin, 2016, 127: 226-233. [11]赵丽珂, 穆冰瑶, 周荣伟,等. 不同免疫抑制剂及甲泼尼龙对小鼠肺间质纤维化的疗效对比[J]. 中国临床保健杂志, 2017, 20 (5): 579-583. [12]陈晓丽. 甲泼尼龙对哮喘患者气道纤维化转化因子的影响[J]. 临床合理用药杂志, 2017, 10(5): 39-40. [13]SHAN G, ZHOU X, YUE X, et al. Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro[J]. Experimental and Therapeutic Medicine, 2016, 11 (5): 1611-1616. [14]LEUS N G, ZWINDERMAN M R, DEKKER F J. Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation[J]. Current Opinion in Chemical Biology, 2016, 33: 160-168. [15]ZIYADEH F N. Mediators of diabetic renal disease: the case fortgf-Beta as the major mediator[J]. Journal of the American Society of Nephrology, 2004, 15(Sup 1): S55-S57. [16]MENG X M, CHUNG A C K, LAN H Y. Role of the TGF-β/BMP-7/Smad pathways in renal diseases[J]. Clinical Science, 2013, 124 (3/4): 243-254. [17]ZHANG L, ZHANG J, XU C, et al. Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells[J]. Drug Design, Development and Therapy, 2015, 9: 4669-4678. [18]NLANDU-KHODO S, NEELISETTY S, PHILLIPS M, et al. Blocking TGF-β and β-Catenin epithelial crosstalk exacerbates CKD[J]. Journal of the American Society of Nephrology, 2017, 28 (12): 3490-3503. [19]CHEN L, YANG T, LU D W, et al. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment[J]. Biomedicine and Pharmacotherapy, 2018, 101: 670-681. [20]MENG X M, TANG P M, LI J, et al. TGF-β/Smad signaling in renal fibrosis[J]. Frontiers in Physiology, 2015, 6: 82. [21]WISASTRA R, DEKKER F J. Inflammation, cancer and oxidative Lipoxygenase activity are intimately linked[J]. Cancers, 2014, 6 (3): 1500-1521. [22]CHEN L F, MU Y J, GREENE W C. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB[J]. The Embo Journal, 2014, 21(23): 6539-6548. |
No related articles found! |
|